Usually, the IL-2 dose used in humans corresponds to 600,000 IU/kg, and it is considered a high dose treatment; in most tumor experiments in mice, an equivalent dose of 30,000 IU is used, corresponding with 1–3 μg of wtIL-2 per dose. Here, IL2 is linked to neoplasm.